Allaying the fears: Midomafetamine with therapy is a medicine
MDMA (now called midomafetamine by the FDA) is a substituted amphetamine first synthesised in 1912 by Merck that has been developed over the
top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
James Bunn
Sep 23 min read
Drug Science and University College London Collaboration: Advancing MDMA-Assisted Therapy
Drug Science and UCL are pleased to announce their collaboration aimed at advancing our understanding of MDMA-assisted psychotherapy.
Jai Whelan, Geoff Noller, and Ryan D Ward
Aug 182 min read
3,4-Methylenedioxymethamphetamine (MDMA) consumption in Aotearoa New Zealand: A quantitative survey exploration
The prevalence of 3,4-methylenedioxymethamphetamine (MDMA) consumption is relatively high in Aotearoa New Zealand, but MDMA use has not been
Allaying the fears: MDMA with therapy is a medicine
MDMA has been developed over the past 30 years by the Multidisciplinary Association for Psychedelic Studies as a novel treatment for PTSD.
Prof Fiona Measham and Adam Waugh
Jun 246 min read
“SIZE MATTERS”: High strength ecstasy pills are back, so harm reduction communications need to adapt
Average pill strength has increased in 2024, back to pre-pandemic levels
Prof David Nutt and Prof Jo Neill
Jun 216 min read
Doubt it not, MDMA is a medicine
The AdCom was asked to make a binary yes-no vote on both the efficacy and benefit-risk of MDMA, with scores of 9-2 and 10-1 against for each
Wim van den Brink
Jun 194 min read
Report of the Dutch State Committee on MDMA: A summary of findings and recommendations
On June 6, 2024, the Dutch State Committee MDMA presented its report entitled “MDMA: Beyond ecstasy” to the Dutch Minister of Medical Care.
Drug Science
May 233 min read
How can we prepare psychiatry for a psychedelic future?
The Therapeutic Goods Administration (TGA) in Australia recently made a groundbreaking decision to reschedule two drugs as treatments for ce
Octavian Dixon Ritchie, Cameron Donley and more
Sep 6, 20231 min read
From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
On February 3, 2023, the Therapeutic Goods Administration (TGA), Australian Government Department of Health and Aged Care, announced that on
Anoek Van Vugt, Josjan Zijlmans and more
Sep 1, 20231 min read
MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians
PTSD in adolescence causes much suffering and has substantial health-care costs. The purpose of this study is to investigate the perspective
Libby Furminger
Jun 29, 202210 min read
Over One Hundred Years of MDMA Research
Written by Libby Furminger History 3,4-Methylenedioxymethamphetamine (MDMA), also known as Mandy, Molly, Ecstasy or ‘E’, is a class A...
Drug Science
Apr 11, 20221 min read
3. MDMA History & Law
Download Module Here #educationalresources #HistoryandLaw
Drug Science
Apr 11, 20221 min read
4. MDMA Pharmacology
Download Module Here #educationalresources #Pharmacology
Drug Science
Oct 23, 20214 min read
Effects of Mixing and Dosing MDMA, LSD, and 2C-B with Dr Friederike Meckel Fischer
Dosing in psychoactive drugs Dosing represents one of the three critical elements that determine the quality of a drug experience,...
Drug Science
Sep 14, 20212 min read
Ask the experts: Psilocybin and MDMA Research
In this webinar, two of the world’s leading psychedelic research experts; Dr Ben Sessa and Dr Meg Spriggs, answer questions on the...
Drug Science
Dec 3, 20202 min read
Clinical Insights - MDMA for Alcohol Use Disorder
Dr Ben Sessa – MDMA for Alcohol Use Disorder Dr Ben Sessa presents the first data from the open-label safety and tolerability proof of...
Drug Science
Jul 14, 20202 min read
Medical MDMA Educational Resources
MDMA (3,4-Methylenedioxymethamphetamine) was first synthesised in 1912 by chemists at the pharmaceutical company, Merck in Germany. In...
Ben Sessa, Chloe Sakal and more
Jul 22, 20192 min read
First safety study of MDMA-assisted psychotherapy in patients with alcohol use disorder
Authors: Ben Sessa, Chloe Sakal, Steve O’Brien and David Nutt Published: July 15, 2019 Read the full paper here (open access) We present...
Drug Science
May 3, 20192 min read
Variability in content of MDMA tablets collected in the UK between 2001 and 2018 - a potential risk to users?
As summer approaches and with an increasing number of outdoor events in the calendar, the pop-up drug scene comes back into focus. As...
Timothy Amoroso
Jul 24, 20182 min read
Are the neurocognitive deficits associated with MDMA caused by statistical deficits in ecstasy research? A systematic review
Author: Timothy Amoroso Published: July 24, 2018 There is growing concern that the majority of modern research may be comprised of false...
Drug Science
Apr 11, 20181 min read
The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985)
3,4-Methylenedioxymethamphetamine (MDMA), also known as ecstasy, was first synthesized in 1912 but first reached widespread popularity as...
bottom of page